Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Poriferous LLC has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These active matters are being handled by 1 distinct examiner within 1 distinct art unit. This concentration suggests a highly focused prosecution environment where a single examiner is responsible for all current active matters in this technical field. The 2 pending office actions represent the core of the company's current efforts to secure patent protection for its medical device technologies.
The busiest examiner for this portfolio is PARIS MARIE BLASS, who is responsible for 2 pending office actions. Because there is only 1 distinct examiner and 1 distinct art unit involved, the company's current prosecution is centralized. This centralization may allow for a more uniform communication strategy during the patent acquisition process. Practitioners can focus their efforts on the specific preferences and historical trends associated with this single examiner and art unit to navigate the 2 pending office actions effectively. Having only 1 distinct examiner to manage for both pending matters simplifies the administrative and legal oversight required for the portfolio, ensuring a consistent approach to prosecution.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLASS, PARIS MARIE | 2 | 54.5% | +39.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18784442 | TISSUE SUSPENSION IMPLANT | BLASS, PARIS MARIE | — |
| 17711174 | TISSUE SUSPENSION IMPLANT | BLASS, PARIS MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18784442 | TISSUE SUSPENSION IMPLANT | BLASS, PARIS MARIE | — |
| 17711174 | TISSUE SUSPENSION IMPLANT | BLASS, PARIS MARIE | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18784442 | TISSUE SUSPENSION IMPLANT | BLASS, PARIS MARIE | — | §103§112 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 17711174 | TISSUE SUSPENSION IMPLANT | BLASS, PARIS MARIE | 3774 | §102§103 | Non-Final OA | — | Pending | Apr 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial